Topic: Epogen
SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits ...
(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.The biotechnology company said in a regulatory filing on ...
(Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market for its flagship drug Epogen.Amgen said in a ...
LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of Epogen, the anemia drug sold ...
LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of Epogen, the anemia drug sold by Amgen.The government ...
LOS ANGELES (Reuters) - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.The agency, which is slated to issue a final decision on the matter in June, also ...
People with chronic? kidney disease do not make enough of the hormone erythropoietin which helps the body produce red blood cells. Epogen is a medication that is frequently used to help increase the number of red blood cells in the body. Epogen ...
A panel of Food and Drug Administration advisers voted not to restrict the use of anemia drugs like Epogen and Aranesp in kidney disease patients, either before they start getting dialysis or when they get it (a $2.6 billion market. ) This ...
Amgen recalls some lots of anemia treatments Epogen and Procrit due to glass flakesABOUT THE RECALL: Some lots of the blockbuster anemia treatments Epogen and Procrit were recalled because the injected drugs may contain glass flakes. Those could cause blood clots, swelling ...
Amgen Inc. is recalling some lots of its blockbuster Epogen and procrit" class="inform">Procrit anemia treatments because the injected drugs may contain glass flakes that could cause blood clots, swelling of veins, immune system reactions and other problems.The Thousand Oaks, Calif., biotechnology company ...
From Around the Web
Video Gallery
-
Safety Advisory on Procrit, Aranesp & Epogen ...
FDA has issued a Public Health Advisory which summarizes several ...2008-03-20 -
Angie's Aranesp Injection (Equivalent to ...
I was nervous making this video so some of the ...2009-03-13 -
Risk Management Program for Procrit, Epogen ...
FDA is requiring that Erythropoiesis-Stimulating Agents (ESAs) be prescribed and ...2010-05-21
